Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Peijia Medical Raises $100 Million for Medical Device Development

publication date: Nov 6, 2019

Peijia Medical, a Suzhou interventional medical device maker, raised $100 million in a series C funding that was led by Matrix Partners China, which also led Peijia's A round. Founded in 2012, Peijia claims to have developed China's first cardiovascular drug-eluting stent and intracranial embolization coil. Other investors in the C round included Lily Asia Ventures, SDIC Fund Management Company, Grand Flight Investment and Chengtong Fund. Peijia claimed the C round is one of the largest venture rounds on record for a China device maker. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital